ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 78 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2017. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $9 | -18.2% | 320 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $11 | +37.5% | 320 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $8 | -38.5% | 320 | 0.0% | 0.00% | -33.3% |
Q4 2022 | $13 | -99.9% | 320 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $11,000 | 0.0% | 320 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $11,000 | -26.7% | 320 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $15,000 | -28.6% | 320 | 0.0% | 0.00% | -25.0% |
Q4 2021 | $21,000 | +5.0% | 320 | 0.0% | 0.00% | -20.0% |
Q3 2021 | $20,000 | +42.9% | 320 | 0.0% | 0.01% | +25.0% |
Q2 2021 | $14,000 | -33.3% | 320 | 0.0% | 0.00% | -20.0% |
Q1 2021 | $21,000 | -16.0% | 320 | 0.0% | 0.01% | -16.7% |
Q4 2020 | $25,000 | +78.6% | 320 | 0.0% | 0.01% | +50.0% |
Q3 2020 | $14,000 | 0.0% | 320 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $14,000 | +55.6% | 320 | 0.0% | 0.00% | +33.3% |
Q1 2020 | $9,000 | -70.0% | 320 | -31.9% | 0.00% | -66.7% |
Q4 2019 | $30,000 | +130.8% | 470 | 0.0% | 0.01% | +125.0% |
Q3 2019 | $13,000 | +8.3% | 470 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $12,000 | +33.3% | 470 | 0.0% | 0.00% | +33.3% |
Q1 2019 | $9,000 | +50.0% | 470 | 0.0% | 0.00% | +50.0% |
Q4 2018 | $6,000 | -33.3% | 470 | 0.0% | 0.00% | -33.3% |
Q3 2018 | $9,000 | +50.0% | 470 | 0.0% | 0.00% | +50.0% |
Q2 2018 | $6,000 | +100.0% | 470 | 0.0% | 0.00% | +100.0% |
Q1 2018 | $3,000 | +50.0% | 470 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $2,000 | 0.0% | 470 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $2,000 | +100.0% | 470 | 0.0% | 0.00% | – |
Q2 2017 | $1,000 | 0.0% | 470 | 0.0% | 0.00% | – |
Q1 2017 | $1,000 | -99.9% | 470 | 0.0% | 0.00% | – |
Q4 2016 | $729,000 | +24200.0% | 470 | 0.0% | 0.00% | -100.0% |
Q3 2016 | $3,000 | – | 470 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Western Financial Corp/CA | 820,320 | $33,272,179 | 21.56% |
Aquilo Capital Management, LLC | 1,103,515 | $44,758,568 | 16.81% |
M28 Capital Management LP | 143,900 | $5,836,584 | 5.56% |
WEALTH EFFECTS LLC | 155,620 | $6,311,951 | 3.60% |
Evolutionary Tree Capital Management, LLC | 92,095 | $3,735,373 | 3.59% |
Privium Fund Management B.V. | 221,015 | $8,867,122 | 3.36% |
JOHNSON & JOHNSON | 247,598 | $10,043 | 2.92% |
COMMODORE CAPITAL LP | 462,111 | $18,743 | 2.82% |
Avidity Partners Management LP | 1,375,000 | $55,770,000 | 1.21% |
Capital Impact Advisors, LLC | 26,853 | $1,089,158 | 1.06% |